Study Stopped
COVID and no plans to move forward
Diversion Device With Breath Control
Interactive Multimedia Diversion Device With Breath Control
1 other identifier
observational
N/A
1 country
1
Brief Summary
The experience for many children who need to undergo anesthesia induction by breathing anesthetic vapors in the operating room is frightening to the child. We have developed a computer-based game system that uses breathing-in and breathing-out as a game controller. We believe that the immersive game experience will encourage breathing patterns ideal for anesthetic induction while providing fun and diversion for the child, lessening or eliminating the fear that typically accompanies breathing anesthetics. The purpose of the study is to determine whether diversion and breathing encouragement offered by a game and this device
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2019
CompletedFirst Posted
Study publicly available on registry
December 23, 2019
CompletedStudy Start
First participant enrolled
January 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
April 1, 2026
March 1, 2026
1 year
December 19, 2019
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Anxiety
Anxiety measured by the PROMIS Anxiety Parent-Proxy questionnaire, minimum 0, maximum 100 points (t-score), higher score means higher anxiety
Administered to parents directly after induction of anesthesia
End-tidal oxygen at the beginning of anesthesia
End-tidal oxygen concentration measured at the start of anesthesia
Measured directly after induction
Anxiety
Anxiety measured by the PROMIS Anxiety Parent-Proxy questionnaire, minimum 0, maximum 100 points (t-score), higher score means higher anxiety
Administered to the anesthesiologist caring for the patient directly after induction of anesthesia
Study Arms (3)
Control
Patients randomized to this group will receive standard of care induction of anesthesia
Study
Patients randomized to this group will receive induction of anesthesia using the Lullabreath game
Music Video
Patients randomized to this group will receive induction of anesthesia using the music video game
Interventions
After consent and assent the child and parent will be introduced the Lullabreath in pre-op. The purpose of Lullabreath will be explained and the Lullabreath will be taught (15 minutes). The parent will complete the PROMIS Proxy Anxiety short form. The children are then taken to the operating room (leave parents) with the Lullabreath. The anesthesiologist will hook the device up to the anesthesia circuit and start the Lullabreath. The child will then undergo induction of anesthesia while playing the Lullabreath.
After consent and assent the child and parent will be introduced to the game in pre-op. The purpose of the game will be explained and the game will be taught (15 minutes). The parent will complete the PROMIS Proxy Anxiety short form. The children are then taken to the operating room (leave parents) with the game. The anesthesiologist will hook the device up to the anesthesia circuit and start the game. The child will then undergo induction of anesthesia while playing the game. The child can choose to watch one of two music videos (Frozen, Lion King)
Eligibility Criteria
4-11 year old children undergoing anesthesia for any procedure without visual impairment, non english speaking, Premature infants and children previously exposed to the chemotherapeutic agent bleomycin
You may qualify if:
- year old children undergoing anesthesia for any procedure
You may not qualify if:
- Visual impairment
- non english speaking
- Premature infants
- children previously exposed to the chemotherapeutic agent bleomycin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah
Salt Lake City, Utah, 84112, United States
Study Officials
- STUDY CHAIR
Kai Kuck, PhD
University of Utah
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 19, 2019
First Posted
December 23, 2019
Study Start
January 31, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
January 31, 2027
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share